Recom Biotek Limited
Founded in 2001 and headquartered in Telangana, India.
2001 | Hyderabad, Telangana (India) | Active
Recom Biotek Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 23 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
About Recom Biotek
Recom Biotek Limited (RBL) is a Public Limited Indian Non-Government Company incorporated in India on 01 June 2001 and has a history of 23 years and eight months. Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sathaiah Vadapally, Sabitha Kota, and Indra Chintakuntla serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231TG2001PLC036830
- Company No.
036830
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Chemicals
Who are the key members and board of directors at Recom Biotek?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sathaiah Vadapally  | Managing Director | 20-Jul-2001 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sabitha Kota | Director | 29-Sep-2008 | Current |
| Indra Chintakuntla | Director | 20-Jul-2001 | Current |
Financial Performance of Recom Biotek.
Recom Biotek Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Recom Biotek?
In 2017, Recom Biotek had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Satya Fabricators Pvt. Ltd.
Indra Chintakuntla is a mutual person
- Mythri Infratech Private Limited
Sathaiah Vadapally is a mutual person
- Sneha Chit Funds Pvt Ltd
Sathaiah Vadapally and Sabitha Kota are mutual person
- Rye Consulting Private Limited
Sabitha Kota is a mutual person
- Prince Laboratories Private Limited
Indra Chintakuntla is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Recom Biotek?
Unlock and access historical data on people associated with Recom Biotek, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Recom Biotek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Recom Biotek's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.